R. Molerón
Impact in
- Otorhinolaryngology top 0.5%
- Head and Neck Cancer Studies
-
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Surgical Treatments
Papers in
-
- Head and Neck Cancer Studies 7
- Genetics 2
- Glioma Diagnosis and Treatment 2
- Co-authors
- Alejandro de la Torre (2 shared papers)Jesús Romero (2 shared papers)Isabel Millán (1 shared paper)Jose Antonio Lopez-Martin (1 shared paper)Ricardo Sánchez‐Prieto (1 shared paper)Alfonso Mariño (1 shared paper)Juan Antonio Vargas (1 shared paper)Alfredo Polo (1 shared paper)
- Journals
- European Journal of Cancer (3 papers)Annals of Oncology (2 papers)The Lancet (1 paper)Pediatric Blood & Cancer (1 paper)International Journal of Radiation Oncology*Biology*Physics (1 paper)
- Partner nations
- United KingdomSpainIreland
In The Last Decade
R. Molerón
16 papers receiving 896 citations
R. Molerón's Hit Papers
Peers
Comparison fields: 5 of 30
- Otorhinolaryngology 611
- Oncology 65
- Radiation 12
- Pulmonary and Respiratory Medicine 32
- Epidemiology 25
Countries citing papers authored by R. Molerón
This map shows the geographic impact of R. Molerón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Molerón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Molerón more than expected).
Fields of papers citing papers by R. Molerón
This network shows the impact of papers produced by R. Molerón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Molerón. The network helps show where R. Molerón may publish in the future.
Co-authors
The 25 scholars most cited alongside R. Molerón, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial Hit paper breakdown → | 2018 | 782 |
| 2 | 2007 | 28 | |
| 3 | 2008 | 24 | |
| 4 | 2009 | 24 | |
| 5 | 2021 | 14 | |
| 6 | 2024 | 6 | |
| 7 | 2021 | 5 | |
| 8 | 2018 | 4 | |
| 9 | 2021 | 4 | |
| 10 | 2024 | 4 | |
| 11 | 2021 | 2 | |
| 12 | 2024 | 2 | |
| 13 | 2011 | 1 | |
| 14 | 2013 | 1 | |
| 15 | 2024 | 1 | |
| 16 | 2025 | 1 | |
| 17 | 2015 | 0 | |
| 18 | 2024 | 0 | |
| 19 | 2026 | 0 |
About R. Molerón
R. Molerón is a scholar working on Otorhinolaryngology, Genetics, Oncology, Endocrinology, Diabetes and Metabolism and Surgery, having authored 19 papers that have together received 903 indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (7 papers), Glioma Diagnosis and Treatment (2 papers), Salivary Gland Tumors Diagnosis and Treatment (1 paper), COVID-19 and healthcare impacts (1 paper), Nonmelanoma Skin Cancer Studies (1 paper), Oral health in cancer treatment (1 paper), Testicular diseases and treatments (1 paper) and Colorectal Cancer Surgical Treatments (1 paper). The work is most often cited by research in Otorhinolaryngology (611 citations), Oncology (65 citations), Radiation (12 citations), Pulmonary and Respiratory Medicine (32 citations) and Epidemiology (25 citations). R. Molerón has collaborated with scholars based in United Kingdom, Spain and Ireland. Frequent co-authors include Alejandro de la Torre, Jesús Romero, Isabel Millán, Jose Antonio Lopez-Martin, Ricardo Sánchez‐Prieto, Alfonso Mariño, Juan Antonio Vargas, Alfredo Polo, José María Jimeno and Juan Carlos Tercero. Their work appears in journals such as European Journal of Cancer, Annals of Oncology, The Lancet, Pediatric Blood & Cancer and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.